Compare $ACXP vs $VSBC | Chartloom

Compare

$ACXP vs $VSBC

Acurx Pharmaceuticals Inc · Vitaspring Biomedical Co. Ltd

ACXP

Acurx Pharmaceuticals Inc

VSBC

Vitaspring Biomedical Co. Ltd

Compare $ACXP vs $VSBC

Comparing Acurx Pharmaceuticals Inc and Vitaspring Biomedical Co. Ltd

ACXPAcurx Pharmaceuticals Inc

VSBCVitaspring Biomedical Co. Ltd

ACXPAcurx Pharmaceuticals Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-54.0%

52W performance

-84.3%

FCF yield

-113.2%

VSBCVitaspring Biomedical Co. Ltd

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-100.0%

52W performance

-100.0%

FCF yield

0.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACXP

VSBC

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

VSBC

Vitaspring Biomedical Co. Ltd

Market Cap

ACXP$5M

VSBC$7M

Enterprise Value

ACXP$-5M

VSBC$9M

Price

ACXP$1.27

VSBC$0.00

P/E Ratio

ACXPN/A

VSBCN/A

P/S Ratio

ACXP0.00x

VSBC0.99x

EV/Sales

ACXP0.00x

VSBC0.99x

EV/EBITDA

ACXP0.00x

VSBC4.29x

P/B Ratio

ACXP0.87x

VSBC3.92x

P/FCF Ratio

ACXPN/A

VSBC765.53x

EV/FCF

ACXP0.84x

VSBC1,044.32x

PEG Ratio

ACXPN/A

VSBCN/A

Forward P/E (NTM)

ACXPN/A

VSBCN/A

Forward P/S (NTM)

ACXPN/A

VSBCN/A

Revenue (TTM)

ACXP$0

VSBC$0

Revenue Growth (YoY)

ACXPN/A

VSBCN/A

Forward Rev Growth

ACXP40.7%

VSBC0.0%

Gross Margin (TTM)

ACXP0.0%

VSBC39.3%

Operating Margin (TTM)

ACXP0.0%

VSBC23.4%

EBITDA Margin (TTM)

ACXP0.0%

VSBC0.0%

Net Margin (TTM)

ACXP0.0%

VSBC18.2%

FCF Margin (TTM)

ACXPN/A

VSBCN/A

Net Income (TTM)

ACXP$-8M

VSBC$-456K

FCF (TTM)

ACXP$-6M

VSBC$9K

EPS (TTM)

ACXP-$1.76

VSBC-$0.00

ROE (TTM)

ACXP-12474.0%

VSBC70.0%

ROA (TTM)

ACXP-8749.0%

VSBC-211240.0%

ROIC (TTM)

ACXP-12474.0%

VSBC70.0%

Cash

ACXP$11M

VSBC$13K

Debt

ACXP$0

VSBC$2M

Net Cash/Debt

ACXP$11M

VSBC$-2M

Current Ratio (TTM)

ACXP3.88x

VSBC0.00x

Quick Ratio (TTM)

ACXP3.80x

VSBC0.00x

Debt/Equity (TTM)

ACXP0.00x

VSBC0.00x

Debt/Assets (TTM)

ACXP0.0%

VSBC0.0%

Interest Coverage (TTM)

ACXPN/A

VSBCN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

VSBC0.00x

Beta

ACXP-2.14

VSBC-1.47

52W Performance

ACXP-84.3%

VSBC-100.0%

YTD Performance

ACXP-54.0%

VSBC-100.0%

% from 52W High

ACXP-84.4%

VSBC-100.0%

% from 52W Low

ACXP3.3%

VSBCN/A

Asset Turnover (TTM)

ACXP0.00x

VSBC2.66x

FCF Yield (TTM)

ACXP-113.2%

VSBC0.1%

Earnings Yield (TTM)

ACXP-137.5%

VSBC-6.9%

Dividend Yield (TTM)

ACXPN/A

VSBCN/A

Rule of 40

ACXP0.0

VSBC0.0

EV/GP/RG

ACXPN/A

VSBCN/A

Ticker research

View ACXP research View VSBC research

Metric	ACXP Acurx Pharmaceuticals Inc	VSBC Vitaspring Biomedical Co. Ltd
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-5M	$9M
Price	$1.27	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.99x
EV/Sales	0.00x	0.99x
EV/EBITDA	0.00x	4.29x
P/B Ratio	0.87x	3.92x
P/FCF Ratio	N/A	765.53x
EV/FCF	0.84x	1,044.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	40.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	39.3%
Operating Margin (TTM)	0.0%	23.4%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	18.2%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-456K
FCF (TTM)	$-6M	$9K
EPS (TTM)	-$1.76	-$0.00
ROE (TTM)	-12474.0%	70.0%
ROA (TTM)	-8749.0%	-211240.0%
ROIC (TTM)	-12474.0%	70.0%
Financial Health
Cash	$11M	$13K
Debt	$0	$2M
Net Cash/Debt	$11M	$-2M
Current Ratio (TTM)	3.88x	0.00x
Quick Ratio (TTM)	3.80x	0.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	-1.47
52W Performance	-84.3%	-100.0%
YTD Performance	-54.0%	-100.0%
% from 52W High	-84.4%	-100.0%
% from 52W Low	3.3%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.00x	2.66x
FCF Yield (TTM)	-113.2%	0.1%
Earnings Yield (TTM)	-137.5%	-6.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View VSBC research

Valuation

P/S Ratio

ACXP

0.00x

VSBC

0.99x

EV/FCF

ACXP

0.84x

VSBC

1,044.32x

Growth & revenue

Forward Revenue Growth

ACXP

40.7%

VSBC

0.0%

Profitability & performance

Gross Margin

VSBC

39.3%

ACXP

0.0%

ROE

VSBC

70.0%

ACXP

-12474.0%

FCF Yield %

VSBC

0.1%

ACXP

-113.2%

52-Week Performance

ACXP

-84.3%

VSBC

-100.0%

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

VSBC

Vitaspring Biomedical Co. Ltd

Market Cap

ACXP$5M

VSBC$7M

Enterprise Value

ACXP$-5M

VSBC$9M

Price

ACXP$1.27

VSBC$0.00

P/E Ratio

ACXPN/A

VSBCN/A

P/S Ratio

ACXP0.00x

VSBC0.99x

EV/Sales

ACXP0.00x

VSBC0.99x

EV/EBITDA

ACXP0.00x

VSBC4.29x

P/B Ratio

ACXP0.87x

VSBC3.92x

P/FCF Ratio

ACXPN/A

VSBC765.53x

EV/FCF

ACXP0.84x

VSBC1,044.32x

PEG Ratio

ACXPN/A

VSBCN/A

Forward P/E (NTM)

ACXPN/A

VSBCN/A

Forward P/S (NTM)

ACXPN/A

VSBCN/A

Revenue (TTM)

ACXP$0

VSBC$0

Revenue Growth (YoY)

ACXPN/A

VSBCN/A

Forward Rev Growth

ACXP40.7%

VSBC0.0%

Gross Margin (TTM)

ACXP0.0%

VSBC39.3%

Operating Margin (TTM)

ACXP0.0%

VSBC23.4%

EBITDA Margin (TTM)

ACXP0.0%

VSBC0.0%

Net Margin (TTM)

ACXP0.0%

VSBC18.2%

FCF Margin (TTM)

ACXPN/A

VSBCN/A

Net Income (TTM)

ACXP$-8M

VSBC$-456K

FCF (TTM)

ACXP$-6M

VSBC$9K

EPS (TTM)

ACXP-$1.76

VSBC-$0.00

ROE (TTM)

ACXP-12474.0%

VSBC70.0%

ROA (TTM)

ACXP-8749.0%

VSBC-211240.0%

ROIC (TTM)

ACXP-12474.0%

VSBC70.0%

Cash

ACXP$11M

VSBC$13K

Debt

ACXP$0

VSBC$2M

Net Cash/Debt

ACXP$11M

VSBC$-2M

Current Ratio (TTM)

ACXP3.88x

VSBC0.00x

Quick Ratio (TTM)

ACXP3.80x

VSBC0.00x

Debt/Equity (TTM)

ACXP0.00x

VSBC0.00x

Debt/Assets (TTM)

ACXP0.0%

VSBC0.0%

Interest Coverage (TTM)

ACXPN/A

VSBCN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

VSBC0.00x

Beta

ACXP-2.14

VSBC-1.47

52W Performance

ACXP-84.3%

VSBC-100.0%

YTD Performance

ACXP-54.0%

VSBC-100.0%

% from 52W High

ACXP-84.4%

VSBC-100.0%

% from 52W Low

ACXP3.3%

VSBCN/A

Asset Turnover (TTM)

ACXP0.00x

VSBC2.66x

FCF Yield (TTM)

ACXP-113.2%

VSBC0.1%

Earnings Yield (TTM)

ACXP-137.5%

VSBC-6.9%

Dividend Yield (TTM)

ACXPN/A

VSBCN/A

Rule of 40

ACXP0.0

VSBC0.0

EV/GP/RG

ACXPN/A

VSBCN/A

Ticker research

View ACXP research View VSBC research

Metric	ACXP Acurx Pharmaceuticals Inc	VSBC Vitaspring Biomedical Co. Ltd
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-5M	$9M
Price	$1.27	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.99x
EV/Sales	0.00x	0.99x
EV/EBITDA	0.00x	4.29x
P/B Ratio	0.87x	3.92x
P/FCF Ratio	N/A	765.53x
EV/FCF	0.84x	1,044.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	40.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	39.3%
Operating Margin (TTM)	0.0%	23.4%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	18.2%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-456K
FCF (TTM)	$-6M	$9K
EPS (TTM)	-$1.76	-$0.00
ROE (TTM)	-12474.0%	70.0%
ROA (TTM)	-8749.0%	-211240.0%
ROIC (TTM)	-12474.0%	70.0%
Financial Health
Cash	$11M	$13K
Debt	$0	$2M
Net Cash/Debt	$11M	$-2M
Current Ratio (TTM)	3.88x	0.00x
Quick Ratio (TTM)	3.80x	0.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	-1.47
52W Performance	-84.3%	-100.0%
YTD Performance	-54.0%	-100.0%
% from 52W High	-84.4%	-100.0%
% from 52W Low	3.3%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.00x	2.66x
FCF Yield (TTM)	-113.2%	0.1%
Earnings Yield (TTM)	-137.5%	-6.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View VSBC research